Literature DB >> 8626549

Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer.

R J Lee1, L Huang.   

Abstract

We have developed a lipidic gene transfer vector, LPDII, where DNA was first complexed to polylysine at a ratio of 1:0.75 (w/w) and then entrapped into folate-targeted pH-sensitive anionic liposomes composed of dioleoyl phosphatidylethanolamine (DOPE)/cholesteryl hemisuccinate/folate-polyethlene glycol-DOPE (6:4:0.01 mol/mol) via charge interaction. LPDII transfection of KB cells, a cell line overexpressing the tumor marker folate receptor, was affected by both the lipid to DNA ratio and the lipid composition. At low lipid to DNA ratios (e.g. 4 and 6), LPDII particles were positively charged; transfection and cellular uptake levels were independent of the folate receptor and did not require a pH-sensitive lipid composition. Meanwhile, transfection and uptake of negatively charged LPDII particles, i.e. those with high lipid to DNA ratios (e.g. 10 and 12), were folate receptor-dependent and required a pH-sensitive lipid composition. The transfection activity of LPDII was lost when the inverted cone-shaped DOPE was replaced by dioleoyl phosphatidylcholine. LPDII particles with lipid to DNA ratios of 4, 6, 10, and 12 were approximately 20-30 times more active than DNA.3-beta-[N-(N',N'-dimethylethane)carbamoyl]cholesterol cationic liposome complexes in KB cells and were much less cytotoxic. On the sucrose gradient, LPDII particles had a migration rate in between those of the free DNA and the DNA.polylysine complex. An electron micrograph of LPDII showed a structure of spherical particles with a positively stained core enclosed in a lipidic envelope with a mean diameter of 74 +/- 14 nm. This novel gene transfer vector may potentially be useful in gene therapy for tumor-specific delivery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626549     DOI: 10.1074/jbc.271.14.8481

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

2.  Compaction of DNA in an anionic micelle environment followed by assembly into phosphatidylcholine liposomes.

Authors:  E A Murphy; A J Waring; S M Haynes; K J Longmuir
Journal:  Nucleic Acids Res       Date:  2000-08-01       Impact factor: 16.971

3.  The role of a microscopic colloidally stabilized phase in solubilizing oligoamine-condensed DNA complexes.

Authors:  Vladimir S Trubetskoy; Jon A Wolff; Vladimir G Budker
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

Review 4.  Tumor ablation and nanotechnology.

Authors:  Rachel L Manthe; Susan P Foy; Nishanth Krishnamurthy; Blanka Sharma; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

5.  Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery.

Authors:  I A Khalil; K Kogure; S Futaki; S Hama; H Akita; M Ueno; H Kishida; M Kudoh; Y Mishina; K Kataoka; M Yamada; H Harashima
Journal:  Gene Ther       Date:  2007-02-01       Impact factor: 5.250

Review 6.  Nonviral gene delivery: what we know and what is next.

Authors:  Xiang Gao; Keun-Sik Kim; Dexi Liu
Journal:  AAPS J       Date:  2007-03-23       Impact factor: 4.009

Review 7.  Lipid-based nanoparticles for nucleic acid delivery.

Authors:  Weijun Li; Francis C Szoka
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 8.  Nonviral gene transfection nanoparticles: function and applications in the brain.

Authors:  Indrajit Roy; Michal K Stachowiak; Earl J Bergey
Journal:  Nanomedicine       Date:  2008-03-03       Impact factor: 5.307

9.  Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery.

Authors:  Xiaogang Pan; Jingjiao Guan; Jung-Woo Yoo; Arthur J Epstein; L James Lee; Robert J Lee
Journal:  Int J Pharm       Date:  2008-03-04       Impact factor: 5.875

Review 10.  Lipid-based nanotherapeutics for siRNA delivery.

Authors:  A Schroeder; C G Levins; C Cortez; R Langer; D G Anderson
Journal:  J Intern Med       Date:  2010-01       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.